Suppr超能文献

[序贯法单纯单孔保乳切除术治疗不同象限早期乳腺癌的疗效]

[Effectiveness of sequential method pure single-port lumpectomy-breast conserving surgery for early-stage breast cancer in different quadrants].

作者信息

Zhou Qianhe, Liu Jianyu, Wang Wenzheng, Li Yingpu, Li Zhigao

机构信息

Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin Heilongjiang, 150081, P. R. China.

出版信息

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024 Jul 15;38(7):793-800. doi: 10.7507/1002-1892.202403083.

Abstract

OBJECTIVE

To compare the effectiveness of sequential method pure single-port lumpectomy-breast conserving surgery (SMPSL-BCS) in treating early-stage breast cancer patients with tumors in different quadrants.

METHODS

A retrospective analysis was conducted on 200 early-stage breast cancer female patients admitted between January 2023 and December 2023. According to the quadrant where the tumor was located, the patients were allocated into the upper outer quadrant group (UO group), lower outer quadrant group (LO group), upper inner quadrant group (UI group), and lower inner quadrant group (LI group), with 50 cases in each group. There was no significant difference ( >0.05) in the baseline data, including age, body mass index, smoking history, marital status, comorbidities, affected breast side, maximum tumor diameter on ultrasound, maximum pathological tumor diameter, clinical tumor stage, molecular subtype, and disease duration. The operation time, intraoperative blood loss, postoperative drainage volume, and extubation time were recorded and compared between groups. Additionally, the occurrence of early-stage complications (1-3 months after operation; including subcutaneous fluid accumulation, incision infection, superficial skin burns) and late-stage complications (>3 months after operation; including pectoralis major muscle adhesion, changes in breast appearance and shape, sensory discomfort) were assessed. At 6 months after operation, the cosmetic outcome of breast-conserving surgery was rated for all groups.

RESULTS

The UO group had the shortest operation time, followed by the UI group, LO group, and LI group, showing significant differences between groups ( <0.05). The UO group had the least intraoperative blood loss, followed by the LO group, UI group, and LI group; except for the difference between UO group and LO group, which was not significant ( >0.05), the differences between the other groups were significant ( <0.05). The UO group had the least postoperative drainage volume, followed by the LO group, UI group, and LI group; except for the difference between LO group and UI group, which was not significant ( >0.05), the differences between the other groups were significant ( <0.05). The extubation time of the LI group was significantly longer than that of the other groups ( <0.05). All patients were followed up 4-12 months, with an average of 8 months. And 193 patients were followed up more than 6 months, including 48 patients in UO group, 47 in LO group, 49 in UI group, and 49 in LI group. In the early-stage period, the LI group had a higher incidence of subcutaneous fluid accumulation after tube removal compared to the UO group and LO group ( <0.05), while there was no significant difference in the incidences of other early complications between groups ( >0.05). In the late-stage period, the LI group had significantly higher incidences of pectoralis major muscle adhesion and changes in breast appearance and shape than UO group and LO group ( <0.05), and a significantly higher incidence of sensory discomfort than UO group ( <0.05). There was no significant difference in the incidences of other late-stage complications between groups ( >0.05). At 6 months after operation, the cosmetic outcomes of breast-conserving surgery were significantly better in UO group, LO group, and UI group than in LI group ( <0.05); there was no significant difference between the other groups ( >0.05).

CONCLUSION

In the treatment of early-stage breast cancer using SMPSL-BCS, patients with tumors located in the upper outer quadrant show the best effectiveness. The effectivenesses are similar for patients with tumors in the lower outer and upper inner quadrants. However, patients with tumors in the lower inner quadrant do not experience significant advantages. Therefore, it is recommended that SMPSL-BCS should not be the first-choice surgical method for patients with tumors in the lower inner quadrant.

摘要

目的

比较序贯法单纯单孔乳房肿瘤切除术-保乳手术(SMPSL-BCS)治疗不同象限早期乳腺癌患者的疗效。

方法

对2023年1月至2023年12月收治的200例早期乳腺癌女性患者进行回顾性分析。根据肿瘤所在象限,将患者分为外上象限组(UO组)、外下象限组(LO组)、内上象限组(UI组)和内下象限组(LI组),每组50例。年龄、体重指数、吸烟史、婚姻状况、合并症、患侧乳房、超声最大肿瘤直径、最大病理肿瘤直径、临床肿瘤分期、分子亚型和病程等基线数据无显著差异(>0.05)。记录并比较各组的手术时间、术中出血量、术后引流量和拔管时间。此外,评估早期并发症(术后1-3个月;包括皮下积液、切口感染、浅表皮肤灼伤)和晚期并发症(术后>3个月;包括胸大肌粘连、乳房外观和形状改变、感觉不适)的发生情况。术后6个月,对所有组保乳手术的美容效果进行评分。

结果

UO组手术时间最短,其次是UI组、LO组和LI组,组间差异有统计学意义(<0.05)。UO组术中出血量最少,其次是LO组、UI组和LI组;除UO组与LO组差异无统计学意义(>0.05)外,其他组间差异有统计学意义(<0.05)。UO组术后引流量最少,其次是LO组、UI组和LI组;除LO组与UI组差异无统计学意义(>0.05)外,其他组间差异有统计学意义(<0.05)。LI组拔管时间明显长于其他组(<0.05)。所有患者随访4-12个月,平均8个月。193例患者随访超过6个月,其中UO组48例,LO组47例,UI组49例,LI组49例。在早期,LI组拔管后皮下积液发生率高于UO组和LO组(<0.05),而其他早期并发症发生率组间差异无统计学意义(>0.05)。在晚期,LI组胸大肌粘连和乳房外观及形状改变的发生率明显高于UO组和LO组(<0.05),感觉不适发生率明显高于UO组(<0.05)。其他晚期并发症发生率组间差异无统计学意义(>0.05)。术后6个月,UO组、LO组和UI组保乳手术的美容效果明显优于LI组(<0.05);其他组间差异无统计学意义(>0.05)。

结论

采用SMPSL-BCS治疗早期乳腺癌时,肿瘤位于外上象限的患者疗效最佳。外下象限和内上象限肿瘤患者的疗效相似。然而,内下象限肿瘤患者未显示出明显优势。因此,建议SMPSL-BCS不应作为内下象限肿瘤患者的首选手术方法。

相似文献

本文引用的文献

4
Oncoplastic breast-conserving surgery for women with primary breast cancer.原发性乳腺癌患者的肿瘤整形保乳手术。
Cochrane Database Syst Rev. 2021 Oct 29;10(10):CD013658. doi: 10.1002/14651858.CD013658.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验